Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice [PDF]
, 2000 Fred O. Risinger +4 more
openalex +1 more source
Clinical Case Reports, Volume 13, Issue 7, July 2025.ABSTRACT Neuroleptic malignant syndrome (NMS) is a rare but life‐threatening reaction associated with the use of dopamine‐modulating agents, which presents with symptoms like high fever, muscle rigidity, and autonomic instability. It is known that both the use of dopamine receptor antagonists and the sudden withdrawal of dopamine receptor agonists can ...
Behnam Abbasi +2 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 118, Issue 1, Page 242-251, July 2025.Although attractive for relevance to real‐world scenarios, real‐world data (RWD) is typically used for drug repurposing and not therapeutic target discovery. Repurposing studies have identified few effective options in neurological diseases such as the rare disease, amyotrophic lateral sclerosis (ALS), which has no disease‐modifying treatments ...
Mohammadali Alidoost +9 more
wiley +1 more source
The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice [PDF]
, 2000 M. Gustavo Murer +12 more
openalex +1 more source
PASTa: An Open‐Source Analysis and Signal Processing Toolbox for Fiber Photometry Data
Current Protocols, Volume 5, Issue 7, July 2025.Abstract Fiber photometry is a rapidly growing technique to record real‐time neural signaling in awake, behaving subjects. However, the processing and analysis of photometry data streams can be complicated, and there is wide divergence in methods across the field.
Rachel M. Donka +4 more
wiley +1 more source
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. [PDF]
Clin Cancer Res, 2019 Prabhu VV +22 more
europepmc +1 more source
Cellular Localization of Dopamine D2 Receptor Messenger RNA in the Rat Trigeminal Ganglion
, 1995 Robert A. Peterfreund +2 more
openalex +1 more source
Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy [PDF]
, 2000 Robert D. Oades +4 more
openalex +1 more source
International Journal of Eating Disorders, Volume 58, Issue 7, Page 1345-1351, July 2025.ABSTRACT Objective Avoidant restrictive food intake disorder (ARFID) is a relatively new diagnostic entity, and no medication has been approved. Recent data suggest that mirtazapine, a tetracyclic antidepressant, could improve outcomes in ARFID. We conducted a retrospective chart review to examine the effects of mirtazapine on ARFID treatment in youth.
Aman Chishti +6 more
wiley +1 more source
Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice [PDF]
, 2000 Kuei Y. Tseng +10 more
openalex +1 more source